Cancer: Thyroid | eHealth News | Page 7

Women who survive breast cancer may have a higher-than-average risk of developing thyroid cancer in the next several years

ENDO: Breast Cancer Linked to Higher Risk of Thyroid Cancer

HealthDay.com - Mar 9, 2015 0

Increased risk seen particularly within five years of breast cancer diagnosis

The kinase inhibitor Lenvima (lenvatinib) has been approved by the U.S. Food and Drug Administration to treat differentiated thyroid cancer that has progressed despite radioactive iodine therapy

FDA Approves Lenvima for Type of Thyroid Cancer

HealthDay.com - Feb 13, 2015 0

To treat differentiated thyroid cancer that has progressed despite radioactive iodine therapy

Oral lenvatinib delayed progression of advanced thyroid cancer by 18 months

Lenvatinib Delays Progression in Advanced Thyroid Cancer

HealthDay.com - Feb 12, 2015 0

Leads to improvement in progression-free survival for radioiodine-refractory thyroid cancer

1...5 67Page 7 of 7

Archives